Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir PrEP in Botswana
NCT00111150Phase 3Terminated
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Sep 2005; status: terminated.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00111150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111150.